# Feature Working, Validation, and Implementation Log

## Purpose
This is the living document for:
- how to run and verify implemented features,
- validation evidence for roadmap testing requirements,
- upcoming feature definitions (use, tests, and status),
- ongoing execution log.

## Feature 1: Evidence-Based Recommendations with PubMed

### Current implementation status
Status: Closed for engineering scope (implemented, integrated, and hardened).

Implemented in:
- `src/clients/pubMedClient.ts`
- `src/services/rxNormOpenFdaDrugInteractionService.ts`
- `src/tools/checkDrugInteractions.ts`
- `src/tools/registerTools.ts`
- `src/types/medicationSafety.ts`
- `src/config/env.ts`
- `.env.example`

### How to see Feature 1 working
1. Install dependencies: `npm install`
2. Build: `npm run build`
3. Start MCP Inspector: `npm run inspect`
4. In Inspector, run tool `check_drug_interactions` with this input:

```json
{
  "medications": ["warfarin", "ibuprofen"],
  "patient_context": {
    "age": 67,
    "conditions": ["atrial fibrillation"],
    "renal_function": "mild impairment"
  }
}
```

5. Verify these fields in `structuredContent.llmSynthesis.evidenceSummaries[0]`:
- `drug1`, `drug2`
- `evidenceLevel` (A/B/C/D)
- `studyCount`
- `confidence`
- `studies[]` (`pmid`, `title`, `journal`, `published`, `link`)
- `synthesis`

Expected behavior:
- If PubMed returns evidence: `evidenceSummaries` is present.
- If PubMed fails or no relevant evidence is found: request still succeeds and `evidenceSummaries` may be omitted.

## Feature 1 testing requirements checklist (roadmap)

Reference: `docs/PHASE_6_7_ROADMAP.md` Feature 1 testing requirements.

### Requirement 1: Test with 50 known drug pairs
Status: Done (automated run completed).

Result snapshot (latest 2026-04-21):
- Total pairs tested: 50
- PubMed request success: 50/50
- Non-empty PubMed result set: 50/50

Execution method:
- Direct PubMed E-Utilities validation sweep executed in terminal using 50 interaction-focused pairs.

### Requirement 2: Verify PubMed API response time (<500ms)
Status: Checked, currently not met in this environment.

Result snapshot (latest 2026-04-21):
- Average latency: 588ms
- P95 latency: 964ms
- Under 500ms: 27/50

Notes:
- First request was a cold-start outlier (~5.0s).
- Feature remains functional, but the strict <500ms external API target is not currently satisfied from this runtime.

### Requirement 3: Cross-check against UpToDate, Lexi-Comp
Status: Pending manual clinical validation.

Reason:
- Requires licensed clinical references and human clinical review workflow.

### Requirement 4: Validate evidence level classification
Status: Done (automated tests).

Validation coverage:
- `tests/unit/pubMedClient.test.ts` now covers evidence level inference for A, B, C, and D.

### Requirement 5: Ensure synthesis accuracy (manual review by pharmacist)
Status: Pending manual pharmacist sign-off.

Reason:
- Requires clinical pharmacist review of generated summaries and recommendations.

## Automated test evidence for Feature 1

Commands executed (2026-04-21):
- `npm run type-check` -> pass
- `npm run lint` -> pass (with known TypeScript version compatibility warning only)
- `npm run test:unit -- pubMedClient rxNormOpenFdaDrugInteractionService checkDrugInteractionsTool` -> pass
- `npm test` -> pass (32 passed suites, 1 skipped)
- `npm run test:unit -- pubMedClient` after added classification tests -> pass

Recurring automation command:
- `npm run validate:feature1` -> runs 50-pair PubMed sweep and appends a timestamped summary in this document.

## PubMed client error analysis

Observed error classes during validation:
- `TypeError: fetch failed` from transient network/TLS/DNS connectivity issues.
- Timeout errors (`PUBMED_TIMEOUT`) when E-Utilities latency exceeds local timeout configuration.
- 429/5xx server responses from PubMed service-side throttling or temporary instability.

Mitigations now implemented in code:
- Exponential retry/backoff for transient network errors and 429/5xx responses.
- `tool` query parameter added for NCBI-friendly request identification.
- Optional `email` and `api_key` query parameters supported for NCBI best-practice identification and better rate handling.
- Retry-aware logging and error context (attempt counts) for easier troubleshooting.

PubMed-only timeout and retry exception (recommended for now):
- Set `PUBMED_TIMEOUT_MS=15000` (or 20000 if your network is high-latency)
- Set `PUBMED_MAX_RETRIES=4`
- Set `PUBMED_CONTACT_EMAIL=<team-email>`
- Set `PUBMED_API_KEY=<ncbi-api-key>` if available

Other robust options if intermittent errors persist:
- Add a scheduled warm-cache job for top interaction pairs so common lookups avoid external latency.
- Add a local evidence snapshot fallback (nightly refreshed PMIDs per high-risk pairs).
- Introduce a circuit-breaker window to temporarily suppress repeated PubMed calls during upstream outages.

## Upcoming features log registry

Use this table to track upcoming features, their use, tests, and readiness.

| Feature ID | Feature | Main use | Planned tool/output | Test plan | Current status |
|---|---|---|---|---|---|
| F1 | Evidence-Based Recommendations with PubMed | Add literature-backed interaction evidence in interaction output | `check_drug_interactions` -> `llmSynthesis.evidenceSummaries` | Unit tests + 50-pair API sweep + manual clinical checks | Closed (engineering scope complete; manual clinical checks pending) |
| F2 | Patient Safety Score Dashboard | Quantified medication risk scoring and improvement opportunities | `calculate_patient_safety_score` tool + dashboard-ready scoring payload | Algorithm unit tests + scenario tests + performance <100ms | In progress (engineering + demo payload complete; manual chart/pharmacist validation pending) |
| F3 | What-If Simulator | Compare risk before/after medication changes | `simulate_medication_change` tool output with before/after snapshots and risk deltas | 100+ scenario tests + deterministic delta checks + <2s target | In progress (backend service + MCP tool + baseline unit tests implemented) |
| F4 | Explainable AI Dashboard | Traceable decision path and observability for clinical confidence | Decision trace capture and dashboard artifact | Trace completeness tests + perf tests + PHI safety checks | Planned |
| F5 | Real-Time Multi-Agent Demo | Show cross-agent orchestration for medication safety | Demo agent workflow with MCP calls | End-to-end scripted scenario tests | Planned |
| F6 | Epic Workflow Integration Mockup | Demonstrate EHR-embedded safety workflow | Mock workflow artifacts + integration narrative | UX walkthrough tests + scenario validation | Planned |

## Execution log

### 2026-04-21
- Implemented Feature 1 PubMed client and integration into interaction pipeline.
- Added output schema/type support for evidence summaries.
- Added/updated tests for Feature 1.
- Ran 50-pair PubMed validation sweep.
- Confirmed Feature 1 requirement status: 2 done, 1 checked-not-met, 2 pending-manual.
- Added PubMed-specific timeout/retry settings and optional NCBI email/API key support.
- Implemented PubMed circuit breaker (failure-threshold + cooldown) to suppress repeated upstream outage noise.
- Re-ran validation and updated evidence snapshots.
- Started Feature 2 implementation: added patient safety score service and MCP tool scaffold with unit tests.
- Hardened Feature 2 testing: added deterministic scoring checks, duplicate-med normalization checks, edge-case tests (0 meds and 30+ meds), SHARP hydration tool-path coverage, and a safety-performance baseline test.
- Added Feature 2 dashboard artifact layer in `calculate_patient_safety_score` output (`dashboardArtifact`) for UI-ready score cards, severity chart data, deduction breakdowns, and action queues.

### 2026-04-27
- Updated demo test playbook to a 6-tool flow including `calculate_patient_safety_score` with dashboardArtifact verification steps.
- Added explicit Feature 2 roadmap checks for dashboardArtifact contract validation and demo readiness.
- Added `npm run generate:feature2-sheet` automation to create `docs/clinical/feature2_review_sheet.csv` with 100 chart IDs and 25/35/30/10 risk-bucket distribution for manual clinical adjudication.
- Began Feature 3: implemented `simulate_medication_change` backend flow (service + MCP tool registration + initial test coverage) to compare before/after safety score and interaction deltas.
- Hardened Feature 3 baseline with deterministic delta/edge-case unit tests and a safety-performance baseline (`tests/safety/whatIfSimulation.performance.safety.test.ts`).
- Added Feature 3 scenario pack artifact at `docs/clinical/feature3_demo_scenarios.json` (10 demo-ready add/remove/replace cases).
- Added repeatable validation command: `npm run validate:feature3`.

## Manual validation sign-off section

Use this section for clinical/manual completion records.

### Feature 2 manual validation packet (ready to run)

Objective:
- Close remaining manual validation items for `calculate_patient_safety_score` and mark Feature 2 fully complete.

Required reviewers:
- 1 clinical pharmacist
- 1 prescribing clinician (internal medicine/family medicine preferred)

Recommended sample set:
- 100 de-identified patient charts
- Mix target: 25 low-risk, 35 medium-risk, 30 high-risk, 10 critical-risk regimens

Review rubric (per chart):
- Score band agreement (A/B/C/D/F or equivalent): pass/fail
- Risk tier agreement (`low|medium|high|critical`): pass/fail
- Major/contraindicated interaction capture: pass/fail
- Beers flag correctness (when age >= 65): pass/fail
- Duplicate therapeutic class flag correctness: pass/fail
- Improvement opportunity clinical appropriateness: pass/fail
- Dashboard artifact completeness (`scoreCard`, `severityChart`, `deductionBreakdown`, `opportunityQueue`, `flagsPanel`): pass/fail

Acceptance thresholds:
- Risk tier agreement >= 90%
- Major/contraindicated capture sensitivity = 100%
- Beers flag precision >= 95% on elderly subset
- Dashboard artifact completeness = 100% of reviewed outputs

Execution steps:
1. Export a de-identified chart set and assign review IDs (`F2-CHART-001` to `F2-CHART-100`).
2. Run `calculate_patient_safety_score` for each chart medication list.
3. Record outputs and reviewer adjudication in the template table below.
4. Calculate final agreement metrics and summarize gaps.
5. Capture sign-off in the two reviewer blocks below.

Starter batch (first 10 charts):
- Goal: complete an initial adjudication wave before scaling to 100 charts.
- Suggested mix target: 2 low risk, 3 medium risk, 3 high risk, 2 critical risk.

| Review ID | Target risk bucket | Patient age band | Medication count target | Primary review focus | Assigned reviewer |
|---|---|---|---:|---|---|
| F2-CHART-001 | low | 18-44 | 1-4 | Baseline score/grade sanity | |
| F2-CHART-002 | low | 45-64 | 3-6 | Low-risk opportunity quality | |
| F2-CHART-003 | medium | 45-64 | 5-8 | Moderate interaction weighting | |
| F2-CHART-004 | medium | 65-74 | 6-10 | Elderly Beers flag precision | |
| F2-CHART-005 | medium | 75-84 | 6-10 | Polypharmacy deduction calibration | |
| F2-CHART-006 | high | 65-74 | 8-12 | Major interaction capture | |
| F2-CHART-007 | high | 75-84 | 10-14 | Duplicate-class risk correctness | |
| F2-CHART-008 | high | 85+ | 8-12 | Beers plus interaction compounding | |
| F2-CHART-009 | critical | 65-74 | 8-14 | Contraindicated/major sensitivity | |
| F2-CHART-010 | critical | 75-84 | 10-16 | End-to-end dashboard completeness | |

Starter batch completion gate:
- [ ] All 10 starter charts reviewed by both roles (pharmacist + prescriber)
- [ ] Agreement metrics computed for starter batch
- [ ] Any repeated disagreement pattern documented before scaling to 100 charts

Feature 2 review tracking table template:

| Review ID | Patient age band | Medication count | Tool risk level | Reviewer risk level | Risk agreement | Major/contra capture | Beers correctness | Duplicate-class correctness | Dashboard completeness | Reviewer notes |
|---|---|---:|---|---|---|---|---|---|---|---|
| F2-CHART-001 | 65-74 | 9 | high | high | pass | pass | pass | pass | pass | |
| F2-CHART-002 | 75-84 | 14 | critical | high | fail | pass | pass | pass | pass | downgrade rationale required |

Feature 2 closure checklist (manual):
- [ ] 100/100 chart reviews completed
- [ ] Pharmacist review completed and signed
- [ ] Prescriber review completed and signed
- [ ] Agreement metrics computed and attached
- [ ] Any rubric failures triaged and resolved
- [ ] Feature 2 moved to fully complete in this log and roadmap

- UpToDate and Lexi-Comp cross-check reviewer:
- Date:
- Sample size reviewed:
- Concordance summary:
- Gaps identified:

- Pharmacist synthesis accuracy reviewer:
- Date:
- Sample size reviewed:
- Accuracy notes:
- Required prompt/model adjustments:

### Feature 2 reviewer sign-off block (copy/fill)

- Reviewer role:
- Reviewer name:
- Date:
- Chart sample size:
- Risk-tier agreement (%):
- Major/contraindicated capture sensitivity (%):
- Beers precision on elderly subset (%):
- Dashboard artifact completeness (%):
- Open safety issues:
- Final recommendation: approve / conditional approve / reject

### Feature 2 progress snapshot (full-working status)

Completed now:
- Engineering implementation (`calculate_patient_safety_score` service + tool path)
- Output contract hardened with `dashboardArtifact`
- Unit coverage for deterministic scoring and key edge cases
- SHARP hydration tool-path coverage
- Safety performance baseline check (`<100ms` p95 with mocked interaction backend)
- Demo readiness docs updated to 6-tool flow

Remaining for full completion:
- Manual chart validation (100 de-identified charts)
- Pharmacist and prescriber sign-off
- Final closure update in roadmap + validation log after manual review

Current completion estimate (Feature 2):
- Engineering + automated validation + demo-readiness: 100%
- Manual clinical validation + sign-off: 0%
- Overall full-working completion: ~85% (pending manual clinical closure)

## Automated validation run history

### 2026-04-21T09:31:23.608Z
- Command: npm run validate:feature1
- Pair count: 50
- Success count: 50/50
- Non-empty hit count: 50/50
- Under 500ms: 18/50
- Average latency: 610ms
- P95 latency: 920ms
- Failures: none



### 2026-04-21T09:45:09.142Z
- Command: npm run validate:feature1
- Pair count: 50
- Success count: 50/50
- Non-empty hit count: 50/50
- Under 500ms: 21/50
- Average latency: 592ms
- P95 latency: 831ms
- Failures: none



### 2026-04-21T13:37:22.878Z
- Command: npm run validate:feature1
- Pair count: 50
- Success count: 50/50
- Non-empty hit count: 50/50
- Under 500ms: 25/50
- Average latency: 648ms
- P95 latency: 1213ms
- Failures: none



### 2026-04-21T13:41:05.255Z
- Command: npm run validate:feature1
- Pair count: 50
- Success count: 50/50
- Non-empty hit count: 50/50
- Under 500ms: 27/50
- Average latency: 588ms
- P95 latency: 964ms
- Failures: none
